Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs.

Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. 

Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.

Biotechnology

Health Care

Life Sciences

Therapeutics

Axoltis Pharma

Org chart

Teams

Similar companies